http://orcid.org/0000-0002-0471-0371
Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Marc Labetoulle, Andrea Leonardi, Pierre-Jean Pisella & Christophe Baudouin. (2022) Ciclosporin A Cationic Emulsion 0.1% for the Management of Dry Eye Disease: Facts That Matter for Eye-Care Providers. Ocular Immunology and Inflammation 0:0, pages 1-9.
Read now
Read now
Louis Tong, Chi Chin Sun, Kyung Chul Yoon, Ruben Lim Bon Siong, Vilavun Puangsricharern & Christophe Baudouin. (2021) Cyclosporine Anionic and Cationic Ophthalmic Emulsions in Dry Eye Disease: A Literature Review. Ocular Immunology and Inflammation 29:7-8, pages 1606-1615.
Read now
Read now
Anastasios G. Konstas, Antoine Labbé, Andreas Katsanos, Frances Meier-Gibbons, Murat Irkec, Konstadinos G. Boboridis, Gábor Holló, Julián García-Feijoo, Gordon N. Dutton & Christophe Baudouin. (2021) The treatment of glaucoma using topical preservative-free agents: an evaluation of safety and tolerability. Expert Opinion on Drug Safety 20:4, pages 453-466.
Read now
Read now
Ngamkae Ruangvaravate, Karnthida Choojun, Benjawan Srikulsasitorn, Jatupol Chokboonpiem, Dechathon Asanatong & Supaporn Trakanwitthayarak. (2020) Ocular Surface Changes After Switching from Other Prostaglandins to Tafluprost and Preservative-Free Tafluprost in Glaucoma Patients. Clinical Ophthalmology 14, pages 3109-3119.
Read now
Read now
Dan Zhang, Yan Zhao, Yan-Ting Yang, Yue Zhao, Dan-Yan Wu, Xiao-Xu Liu, Zheng Shi, Jue Hong, Jie Liu & Xiao-Peng Ma. (2020) A Mechanism Study of Electroacupuncture for Dry Eye Syndrome by Targeting Conjunctival Cytokine Expressions. Current Eye Research 45:4, pages 419-427.
Read now
Read now
Kostas G. Boboridis, Nikolaos Kozeis & Anastasios GP. Konstas. (2020) Revisiting Ocular Allergy: Evaluating Symptoms, Benzalkonium Chloride and Efficacy of Topical Ketotifen 0.025%. Ocular Immunology and Inflammation 28:2, pages 188-190.
Read now
Read now
Evelina Marinova, Dimitar Dabov & Yani Zdravkov. (2020) Ophthalmic complaints in face-mask wearing: prevalence, treatment, and prevention with a potential protective effect against SARS-CoV-2. Biotechnology & Biotechnological Equipment 34:1, pages 1323-1335.
Read now
Read now
Articles from other publishers (20)
Anastasios-Georgios Konstas, Konstadinos G. Boboridis, Georgios P. Athanasopoulos, Anna-Bettina Haidich, Irini C. Voudouragkaki, Eirini Pagkalidou, Andreas Katsanos & L. Jay Katz. (2023) Changing from preserved, to preservative-free cyclosporine 0.1% enhanced triple glaucoma therapy: impact on ocular surface disease—a randomized controlled trial. Eye 37:17, pages 3666-3674.
Crossref
Crossref
Leyla Asena & Dilek Dursun Altınörs. (2023) Application of topical 2% cyclosporine A in inflammatory ocular surface diseases. International Ophthalmology.
Crossref
Crossref
Tung-Lin Chiang, Yi-Chen Sun, Jo-Hsuan Wu, Ying-Tung Hsieh, Wei-Lun Huang & Wei-Li Chen. (2022) The ocular graft-versus-host disease: the path from current knowledge to future managements. Eye 37:10, pages 1982-1992.
Crossref
Crossref
Yuan-Hsi Chan & Chi-Chin Sun. (2023) Efficacy and safety of topical cyclosporine 0.1% in moderate-to-severe dry eye disease refractory to topical cyclosporine 0.05% regimen. Taiwan Journal of Ophthalmology 13:1, pages 68.
Crossref
Crossref
V.V. Brzheskiy. (2023) Modern possibilities of pathogenetically oriented therapy for dry eye syndrome. Vestnik oftal'mologii 139:2, pages 95.
Crossref
Crossref
Takashi Kojima, Zuguo Liu, Murat Dogru, Norihiko Yokoi, Kyung Chul Yoon, Louis Tong, Chi Chin Sun, Vilavun Puangsricharern, Chi Hoang Viet Vu & Kazuo Tsubota. 2023. Dry Eye Disease. Dry Eye Disease
181
202
.
Luca Agnifili, Matteo Sacchi, Michele Figus, Chiara Posarelli, Rosario Alfio Umberto Lizzio, Paolo Nucci & Leonardo Mastropasqua. (2022) Preparing the ocular surface for glaucoma filtration surgery: an unmet clinical need. Acta Ophthalmologica 100:7, pages 740-751.
Crossref
Crossref
Nilgün Yıldırım, Banu Bozkurt, Nurşen Yüksel, Halil Ateş, Rana Altan-Yaycıoğlu, Özcan Ocakoğlu, Ayşe Burcu, Ilgaz Yalvaç, Özlem Evren Kemer & Mehmet Orhan. (2022) Prevalence of Ocular Surface Disease and Associated Risk Factors in Glaucoma Patients: A Survey Study of Ophthalmologists. Turkish Journal of Ophthalmology 52:5, pages 302-308.
Crossref
Crossref
Wenxin Zhao, Jing Yang, Yinglin Liao, Hubert Yuenhei Lao, Quanbin Huang, Ling Jin, Jing Sun, Fen Huang & Lingyi Liang. (2022) Comparable meibomian gland changes in patients with and without ocular graft-versus-host disease after hematopoietic stem cell transplantation. The Ocular Surface 25, pages 1-7.
Crossref
Crossref
Kemal Bayrakceken & Adem Ugurlu. (2022) Comparison of the clinical effects of two different doses (0.05% and 0.1%) of topical cyclosporine A in dry eyes with meibomian gland dysfunction. Revista Brasileira de Oftalmologia 81.
Crossref
Crossref
Michael D. Wagoner, Kenneth R. Kenyon & Peter S. Hersh. 2022. Albert and Jakobiec's Principles and Practice of Ophthalmology. Albert and Jakobiec's Principles and Practice of Ophthalmology
699
718
.
Edward J. Holland, Mitchell A. Jackson, Eric Donnenfeld, Rebecca Piccolo, Alisa Cohen, Stefano Barabino, Maurizio Rolando & Francisco C. Figueiredo. (2021) Efficacy of Lifitegrast Ophthalmic Solution, 5.0%, in Patients With Moderate to Severe Dry Eye Disease. JAMA Ophthalmology 139:11, pages 1200.
Crossref
Crossref
Jonghwa KimTae Kyu MoonHyeon Jeong YoonYong Sok JiKyung Chul Yoon. (2021) Efficacy of Switching from Cyclosporine A 0.05% Anionic Emulsion to Cyclosporine A 0.1% Cationic Emulsion in Patients with Dry Eye Associated with Sjögren's Syndrome. Journal of Ocular Pharmacology and Therapeutics 37:8, pages 472-478.
Crossref
Crossref
Do Hee Park, Hyung Nam Jin, Hee Su Yoon, Hyeon Jeong Yoon & Kyung-Chul Yoon. (2021) Assessment of the Compliance with 0.1% Cyclosporine A in Dry-Eye Patients with Sjögren's Syndrome. Journal of the Korean Ophthalmological Society 62:7, pages 895-903.
Crossref
Crossref
Michael D. Wagoner, Kenneth R. Kenyon & Peter S. Hersh. 2020. Albert and Jakobiec's Principles and Practice of Ophthalmology. Albert and Jakobiec's Principles and Practice of Ophthalmology
1
21
.
Lydia J. Beeken, Darren S.J. Ting & Laura E. Sidney. (2021) Potential of mesenchymal stem cells as topical immunomodulatory cell therapies for ocular surface inflammatory disorders. Stem Cells Translational Medicine 10:1, pages 39-49.
Crossref
Crossref
Mohamud A. Verjee, Ashley R. Brissette & Christopher E. Starr. (2020) Dry Eye Disease: Early Recognition with Guidance on Management and Treatment for Primary Care Family Physicians. Ophthalmology and Therapy 9:4, pages 877-888.
Crossref
Crossref
Rujun Jin, Ying Li, Lan Li, Dong Hwan Kim, Che Dong Yang, Han Sun Son, Jung Han Choi, Hyeon Jeong Yoon & Kyung Chul Yoon. (2020) Anti‑inflammatory effects of glycine thymosin�β4 eye drops in experimental dry eye. Biomedical Reports.
Crossref
Crossref
Eleonora Terreni, Patrizia Chetoni, Silvia Tampucci, Susi Burgalassi, Ali Al-kinani, Raid Alany & Daniela Monti. (2020) Assembling Surfactants-Mucoadhesive Polymer Nanomicelles (ASMP-Nano) for Ocular Delivery of Cyclosporine-A. Pharmaceutics 12:3, pages 253.
Crossref
Crossref
Abhirup Mandal, Vrinda Gote, Dhananjay Pal, Abayomi Ogundele & Ashim K. Mitra. (2019) Ocular Pharmacokinetics of a Topical Ophthalmic Nanomicellar Solution of Cyclosporine (Cequa®) for Dry Eye Disease. Pharmaceutical Research 36:2.
Crossref
Crossref